These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26878123)

  • 41. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
    Marek K; Jennings D; Tamagnan G; Seibyl J
    Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exercise Therapy for Parkinson's Disease: Pedaling Rate Is Related to Changes in Motor Connectivity.
    Shah C; Beall EB; Frankemolle AM; Penko A; Phillips MD; Lowe MJ; Alberts JL
    Brain Connect; 2016 Feb; 6(1):25-36. PubMed ID: 26414696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.
    Reynolds GO; Otto MW; Ellis TD; Cronin-Golomb A
    Mov Disord; 2016 Jan; 31(1):23-38. PubMed ID: 26715466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal stem cell transplantation and aerobic exercise for Parkinson's disease: therapeutic assets beyond the motor domain.
    Berrío Sánchez J; Cucarian Hurtado J; Barcos Nunes R; de Oliveira AA
    Rev Neurosci; 2019 Jan; 30(2):165-178. PubMed ID: 29959887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incorporating oral health into interprofessional care teams for patients with Parkinson's disease.
    Rozas NS; Sadowsky JM; Jones DJ; Jeter CB
    Parkinsonism Relat Disord; 2017 Oct; 43():9-14. PubMed ID: 28739426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is physical exercise beneficial for persons with Parkinson's disease?
    Crizzle AM; Newhouse IJ
    Clin J Sport Med; 2006 Sep; 16(5):422-5. PubMed ID: 17016120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repetitive transcranial magnetic stimulation to improve mood and motor function in Parkinson's disease.
    Helmich RC; Siebner HR; Bakker M; Münchau A; Bloem BR
    J Neurol Sci; 2006 Oct; 248(1-2):84-96. PubMed ID: 16793065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-motor extranigral signs and symptoms in Parkinson's disease.
    Wolters ECh
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of LTP-like plasticity in primary motor cortex in Parkinson's disease.
    Suppa A; Marsili L; Belvisi D; Conte A; Iezzi E; Modugno N; Fabbrini G; Berardelli A
    Exp Neurol; 2011 Feb; 227(2):296-301. PubMed ID: 21145888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effectiveness of Tai Chi for patients with Parkinson's disease: study protocol for a randomized controlled trial.
    Yang Y; Hao YL; Tian WJ; Gong L; Zhang K; Shi QG; Sun DF; Li CL; Zhao ZL
    Trials; 2015 Mar; 16():111. PubMed ID: 25873334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. When does Parkinson's disease begin?
    Gaig C; Tolosa E
    Mov Disord; 2009; 24 Suppl 2():S656-64. PubMed ID: 19877243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parkinson's disease: clinical aspects.
    Klockgether T
    Cell Tissue Res; 2004 Oct; 318(1):115-20. PubMed ID: 15365814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of 2 different water-based exercise training programs in patients with Parkinson's disease: a pilot study.
    Ayán C; Cancela J
    Arch Phys Med Rehabil; 2012 Oct; 93(10):1709-14. PubMed ID: 22497803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are studies of motor cortex plasticity relevant in human patients with Parkinson's disease?
    Bologna M; Suppa A; Conte A; Latorre A; Rothwell JC; Berardelli A
    Clin Neurophysiol; 2016 Jan; 127(1):50-59. PubMed ID: 25792075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-dopaminergic treatments in development for Parkinson's disease.
    Fox SH; Brotchie JM; Lang AE
    Lancet Neurol; 2008 Oct; 7(10):927-38. PubMed ID: 18848312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of stem cells in Parkinson's disease.
    Gupta A; Dawson TM
    Neurosurg Clin N Am; 2007 Jan; 18(1):129-42, x-xi. PubMed ID: 17244560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.